ArticleMolecular plant pathology2026
PmWRKY-10 Enhances Pine Wilt Disease Resistance by Promoting Pinosylvin Monomethyl Ether Biosynthesis Through Transcriptional Activation of PmPMT2-1.
Article in Molecular plant pathology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Pine wilt disease (PWD), caused by the pine wood nematode (PWN, Bursaphelenchus xylophilus), poses a severe threat to global pine forests. Plants can enhance their resistance to external stresses by eliciting secondary metabolites; however, the transcriptional regulatory mechanisms governing this defence response in pines remain largely unexplored. Here, we report a novel defence regulatory module in Pinus massoniana. PmWRKY-10 may participate in PWN resistance by regulating the biosynthesis of the nematicidal metabolite pinosylvin monomethyl ether (PME). We first demonstrated that PME accumulation is closely linked to resistance in P. massoniana and provided evidence that PME exhibits direct and potent nematicidal activity against PWN in vitro. By integrating multi-omics profiling with weighted gene co-expression network analysis (WGCNA), we identified PmPMT2-1 as a key candidate associated with PME biosynthesis and accumulation, while recognizing that it is unlikely to function as the sole rate-limiting determinant. Functional analyses demonstrated that PmPMT2-1 overexpression promoted PME accumulation and enhanced resistance, whereas silencing the gene impaired both processes. Mechanistically, we identified PmWRKY-10 as an upstream transcriptional activator that directly binds to the W-box element in the PmPMT2-1 promoter, inducing its transcription. Our work delineates a complete PmWRKY-10→PmPMT2-1→PME transcriptional-metabolic pathway that is essential for stilbene-based resistance in pine. This discovery not only provides fundamental insights into the inducible defence mechanisms of conifers but also identifies key genetic targets for breeding resistant varieties and developing sustainable forest management strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.